Document Detail


Muscle microvascular oxygenation in chronic heart failure: role of nitric oxide availability.
MedLine Citation:
PMID:  16911248     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To test the hypothesis that diminished vascular nitric oxide availability might explain the inability of individuals with chronic heart failure (CHF) to maintain the microvascular PO(2)'s (PO(2mv) proportional, variant O(2) delivery-to-uptake ratio) seen in healthy animals. METHODS: We superfused sodium nitroprusside (SNP; 300 microm), Krebs-Henseleit (control, CON) and L-nitro arginine methyl ester (L-NAME; 1.5 mM) onto the spinotrapezius muscle and measured PO(2mv) by phosphorescence quenching in female Sprague-Dawley rats (n = 26) at rest and during twitch contractions (1 Hz). Seven rats served as controls (Sham) while CHF was induced by myocardial infarction. CHF rats were grouped as moderate (MOD; n = 15) and severe CHF (SEV; n = 4) according to morphological data and baseline PO(2mv). RESULTS: In contrast to Sham and MOD, L-NAME did not affect the PO(2mv) response (dynamics and steady-state) of SEV when compared with CON. SNP restored the PO(2mv) profile of SEV to that seen in Sham animals during CON. Specifically, the effect of L-NAME expressed as Delta(L-NAME - CON) were: Baseline PO(2mv) [in mmHg, DeltaSham = -7.0 +/- 1.6 (P < 0.05); DeltaSEV =-1.2 +/- 2.1], end-contractions PO(2mv) [in mmHg, DeltaSham = -5.0 +/- 1.0 (P < 0.05); DeltaSEV = -2.5 +/- 0.5] and time constant of PO(2mv) decrease [in s, DeltaSham = -6.5 +/- 3.0 (P < 0.05); DeltaSEV = -3.2 +/- 1.8]. CONCLUSION: These data provide the first direct evidence that the pathological profiles of PO(2mv) associated with severe CHF can be explained, in part, by a diminished vascular NO availability.
Authors:
L F Ferreira; K S Hageman; S A Hahn; J Williams; D J Padilla; D C Poole; T I Musch
Related Documents :
18514618 - Oral amino acid supplements improve exercise capacities in elderly patients with chroni...
18391638 - Exercise training increases oxygen uptake efficiency slope in chronic heart failure.
2084278 - Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in ...
16310408 - Ve/vco2 slope is associated with abnormal resting haemodynamics and is a predictor of l...
6965408 - A new generator for ionic gallium-68.
6177268 - Refractory period after exercise-induced asthma unexplained by respiratory heat loss.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta physiologica (Oxford, England)     Volume:  188     ISSN:  1748-1708     ISO Abbreviation:  Acta Physiol (Oxf)     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-08-16     Completed Date:  2007-05-29     Revised Date:  2009-02-03    
Medline Journal Info:
Nlm Unique ID:  101262545     Medline TA:  Acta Physiol (Oxf)     Country:  England    
Other Details:
Languages:  eng     Pagination:  3-13     Citation Subset:  IM    
Affiliation:
Clarenburg Research Laboratory, Department of Anatomy and Physiology, and Department of Kinesiology, Kansas State University, Manhattan, KS 66506-5802, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Vessels / metabolism*
Exercise Tolerance
Heart Failure / metabolism*
Male
Microcirculation
Muscle, Skeletal / blood supply*
Myocardial Infarction / metabolism
NG-Nitroarginine Methyl Ester / pharmacology
Nitric Oxide / metabolism*
Nitric Oxide Synthase / antagonists & inhibitors
Nitroprusside / pharmacology
Oxygen / metabolism*
Rats
Rats, Sprague-Dawley
Vasodilator Agents / pharmacology
Grant Support
ID/Acronym/Agency:
AG-19228/AG/NIA NIH HHS; HL-50306/HL/NHLBI NIH HHS; HL-69739/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 10102-43-9/Nitric Oxide; 15078-28-1/Nitroprusside; 50903-99-6/NG-Nitroarginine Methyl Ester; 7782-44-7/Oxygen; EC 1.14.13.39/Nitric Oxide Synthase
Comments/Corrections
Comment In:
Acta Physiol (Oxf). 2006 Sep;188(1):1   [PMID:  16911247 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differences in weaning practice, food and nutrient intake between breast- and formula-fed 4-month-ol...
Next Document:  Contribution of systemic arterial compliance and systemic vascular resistance to effective arterial ...